P2.04-91 Target Antigen Levels in NSCLC Define a Clinically Relevant Activation Threshold for NY-ESO-1c259 TCR T-Cell Therapy

I. Eleftheriadou,S. Brett, A. Domogala, L. Patasic, M. Kijewska, K. Soor,J. Jing, J. Euesden,K. Auger, R. Roberts,S. O’sullivan,L. Castelletti,M. Damm, J. Klapwijk, J. Spaull,D. Pankov, L. Johnsons,A. Shalabi,C. Britten

JOURNAL OF THORACIC ONCOLOGY(2019)

引用 0|浏览30
暂无评分
关键词
Pre-clinical evidence,NYESO-1 TCR T Cell therapy,Cell Therapy for Lung Cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要